搜索筛选:
搜索耗时5.2573秒,为你在为你在102,285,761篇论文里面共找到 11 篇相符的论文内容
类      型:
[会议论文] 作者:Yuanyuan Kong, 来源:国际预防自杀协会(IASP)第26届世界大会 年份:2011
[期刊论文] 作者:Guang Yang,Qianqiao Zhang,Yuanyuan Kong,Bingqian Xie,Minjie Gao,Yi Tao,Hongwei Xu, 来源:生物化学与生物物理学报(英文版) 年份:2015
[会议论文] 作者:Jumei Shi,Yuanyuan Kong,Bo Li,Shuaikang Chang,Zhijian Xu,Yi Tao,Weiliang Zhu, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Jumei Shi,Yuanyuan Kong,Liangning Hu,Kang Lu,Yingchong Wang,Gege Chen,Yongsheng Xie, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Yong Cui,Jingfen Sun,Hao Li,Jiayun Guo,Guan Shi,Bingqun Wu,Mingliang Liu,Dong Chang,Tianyou Wang,Yuanyuan Kong, 来源:中国医师协会胸外科医师分会2015年会、第六届全国胸外科学术大会暨第八届浙江省胸部肿瘤论坛 年份:2015
Background:Patients with pathological stage Ⅰ non-small-cell lung cancer (NSCLC) after surgery have different prognosis.This study was to investigate clinical significance of the variances of serum CE...
[会议论文] 作者:Shiwei Li,Shibin Xu,Yanli Ma,Shuang Wu,Yu Feng,Qingpo Cui,Lifeng Chen,Shuang Zhou,Yuanyuan Kong,Xiaoyu, 来源:第六届细胞结构与功能的信号基础研讨会 年份:2016
[会议论文] 作者:Shiwei Li,Shibin Xu,Yanli Ma,Shuang Wu,Yu Feng,Qingpo Cui,Lifeng Chen,Shuang Zhou,Yuanyuan Kong,Xiaoyu, 来源:7th Asia - Pacific Celegans Meeting(第七届亚太秀丽隐杆线虫学术会议) 年份:2016
[期刊论文] 作者:Bo Li,Jinfeng Zhou,Zhijian Xu,Huiqun Wu,Yong Zhang,Dongliang Song,Liangning Hu,Ye Lu,Wenxuan Bu,Yuanyuan Kong, 来源:生物化学与生物物理学报(英文版) 年份:2020
Diffuse large B-cell lymphoma (DLBCL) is the most common category and disease entity of non-Hodgkin lymphoma.Osalmide and pterostilbene are natural products wit...
[期刊论文] 作者:Guang Yang,Bingqian Xie,Xiucai Lan,Yingcong Wang,Dandan Yu,Liangning Hu,Yongsheng Xie,Wenxuan Bu,Yuanyuan Kong, 来源:生物化学与生物物理学报(英文版) 年份:2018
MCT-1 (multiple copies in T-cell lymphoma-1),a novel oncogene,was originally identified in T-cell lymphoma.A recentstudy has demonstrated that MCT-1 is highly e...
[会议论文] 作者:Xiaojuan Ou,Xiaoyuan Xu,Hui Ma,Youqing Xu,Xiaoqing Liu,Jialing Zhou,Dongyang Sun,Yameng Sun,Lin Wang,Yuanyuan Kong, 来源:中华医学会第十七次全国病毒性肝炎及肝病学术会议暨2015年中华医学会感染病学分会年会、中华医学会肝病学分会年会 年份:2015
Aims: To investigate clinical effects of two anti-viral therapies entecavir(ETV)alone vs Lamivudine plus adefovir combination(LAM+ADV)on HBV related compensated liver cirrhosis....
[会议论文] 作者:Hong You,Yuanyuan Kong,Jinlin Hou,Lai Wei,Yuexin Zhang,Junqi Niu,Tao Han,Xiaojuan Ou,Xiaoguang Dou,Jia, 来源:2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 年份:2014
Background:Male sex and advancing age are known factors associated with chronic hepatitis B disease progression and cirrhosis.However,few studies have explored the risk of the elderly women for HBV-as...
相关搜索: